Fukushima M
Gan To Kagaku Ryoho. 1983 Jul;10(7):1591-7.
During the past decade a number of pioneering knowledge of neovascularization induced by neoplasm have been accumulated and a clinical application of anti-angiogenesis treatment seems to be launched within very near future. While the most Japanese research workers in the medical field are still dreaming of immunological approaches to cancers. But now we should stand on the wide view of basic biology of cancer and open searches for newer attacking targets of cancers. Such a newer modality may be included in biological treatment against not only tumor growth but also invasion, angiogenesis, and metastasis. As an example of a search for newer attacking target of cancer, here I proposed a view point regarding tumor angiogenesis as a symbiotic system of tumor cells and endothelial cells and I reviewed briefly on recent aspects of angiogenesis and anti-angiogenesis, introducing works of Drs. Folkman, Fenselau, Kumar, Weiss, Rifkin, Langer, Eisenstein, Gullino, and others. I hope this short review may attract many more research workers to the "virgin" field of angiogenesis.
在过去十年中,已经积累了一些关于肿瘤诱导新生血管形成的开创性知识,并且抗血管生成治疗的临床应用似乎将在不久的将来开展。虽然大多数日本医学领域的研究人员仍梦想着采用免疫方法治疗癌症。但现在我们应该站在癌症基础生物学的广阔视角上,公开寻找癌症新的攻击靶点。这种新的治疗方式可能包括针对肿瘤生长、侵袭、血管生成和转移的生物治疗。作为寻找癌症新攻击靶点的一个例子,在此我提出了一种观点,即将肿瘤血管生成视为肿瘤细胞与内皮细胞的共生系统,并简要回顾了血管生成和抗血管生成的最新研究进展,介绍了福克曼博士、芬塞劳博士、库马尔博士、魏斯博士、里夫金博士、兰格博士、艾森斯坦博士、古利诺博士等人的研究成果。我希望这篇简短的综述能吸引更多研究人员投身于血管生成这个“处女地”领域。